Hello and Welcome to Patientsville.com, Your Source for all PERFALGAN information. We are dedicated to provide You with PERFALGAN safety information. Learn about PERFALGAN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
PERFALGAN Safety Reports
Total PERFALGAN reports: 4.PERFALGAN FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 3.
Take PERFALGAN Side Effects Survey or Share Your PERFALGAN Story. Read More Here.
Health Professional from FRANCE reported PERFALGAN problem on Jan 17, 2007. Female patient, 80 years of age, was diagnosed with spinal cord ischaemia and was treated with PERFALGAN. After drug was administered, patient experienced the following problems/side effects: fixed eruption. PERFALGAN dosage: unknown. During the same period patient was treated with PLAVIX, LOVENOX. Patient was hospitalized. Patient recovered.
PERFALGAN problem was reported by a Physician from LEBANON on Feb 23, 2007. Female patient, 75 years of age, weighting 172.0 lb, was diagnosed with pyrexia, pneumonia, ulcer, arrhythmia, hypertension, cerebrovascular accident, thrombosis prophylaxis and was treated with PERFALGAN. After drug was administered, patient experienced the following problems/side effects: pneumonia, septic shock. PERFALGAN dosage: unknown. During the same period patient was treated with BISOLVAN, OMETON, AMIODARONE, AMLODIPINE, PIRACETAM, LIPANOR, LOVENOX, PLAVIX. Patient died on 02/12/2007.
Health Professional from FRANCE reported PERFALGAN problem on May 29, 2007. Male patient, 61 years of age, was diagnosed with arthralgia, hypertension, arthritis bacterial and was treated with PERFALGAN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, thrombocytopenia, toxic skin eruption. PERFALGAN dosage: unknown. During the same period patient was treated with COAPROVEL, ORBENIN CAP, RIFADIN, GENTALLINE, VOLTAREN. Patient was hospitalized. Patient recovered.
PERFALGAN problem was reported by a Health Professional from FRANCE on June 18, 2007. Male patient, 61 years of age, was diagnosed with arthralgia, hypertension, arthritis bacterial and was treated with PERFALGAN. After drug was administered, patient experienced the following problems/side effects: renal failure acute, thrombocytopenia, toxic skin eruption. PERFALGAN dosage: unknown. During the same period patient was treated with COAPROVEL, ORBENIN CAP, RIFADIN, GENTALLINE, VOLTAREN. Patient was hospitalized. Patient recovered.